THU122 Effects Of A GLP-1 Agonist On Consumption Of Alcohol In Patients Treated For Smoking Cessation
Leila Probst(University Hospital of Basel), Bettina Winzeler(University of Basel), Sophia Lengsfeld(University of Basel), Andrea Meienberg(University Hospital of Basel), Thilo Burkard(University Hospital of Basel), Mirjam Christ-crain(University Hospital of Basel), Sophie Monnerat(University of Basel), Cemile Bathelt(University of Basel)
Cited by 1
Related Papers
Effects of dulaglutide on alcohol consumption during smoking cessation
|JCI Insight|2023|75
Effects of the glucagon-like peptide-1 receptor agonist dulaglutide on sexuality in healthy men: a randomised, double-blind, placebo-controlled crossover study
|EBioMedicine|2024|17
Effects of Glucagon-Like Peptide-1 Analogs on Sexual Desire: A randomized, double-blind, placebo-controlled crossover trial
|Endocrine Abstracts|2023|2
Effects of glucagon-like peptide-1 analogs on prolactin: a randomized, double-blind, placebo-controlled crossover trial
|Endocrine Abstracts|2024|1
Changes in fibroblast growth factor 21 levels associated with alcohol consumption and smoking cessation
|Endocrine Connections|2025|1